These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2468 related articles for article (PubMed ID: 23065822)

  • 1. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.
    Diamanti-Kandarakis E; Dunaif A
    Endocr Rev; 2012 Dec; 33(6):981-1030. PubMed ID: 23065822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome.
    Corbould A; Zhao H; Mirzoeva S; Aird F; Dunaif A
    Diabetes; 2006 Mar; 55(3):751-9. PubMed ID: 16505239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
    Dunaif A
    Endocr Rev; 1997 Dec; 18(6):774-800. PubMed ID: 9408743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in women with polycystic ovary syndrome.
    Dunaif A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S13-4. PubMed ID: 16798274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
    Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome.
    Holte J
    Baillieres Clin Endocrinol Metab; 1996 Apr; 10(2):221-47. PubMed ID: 8773746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome.
    Wu XK; Zhou SY; Liu JX; Pöllänen P; Sallinen K; Mäkinen M; Erkkola R
    Fertil Steril; 2003 Oct; 80(4):954-65. PubMed ID: 14556818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.
    Conway G; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Franks S; Gambineri A; Kelestimur F; Macut D; Micic D; Pasquali R; Pfeifer M; Pignatelli D; Pugeat M; Yildiz BO;
    Eur J Endocrinol; 2014 Oct; 171(4):P1-29. PubMed ID: 24849517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and the polycystic ovary syndrome.
    Macut D; Bjekić-Macut J; Rahelić D; Doknić M
    Diabetes Res Clin Pract; 2017 Aug; 130():163-170. PubMed ID: 28646699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
    Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
    J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and polycystic ovary syndrome.
    Barber TM; Franks S
    Clin Endocrinol (Oxf); 2021 Oct; 95(4):531-541. PubMed ID: 33460482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male PCOS equivalent and nutritional restriction: Are we stepping forward?
    Di Guardo F; Cerana MC; D'urso G; Genovese F; Palumbo M
    Med Hypotheses; 2019 May; 126():1-3. PubMed ID: 31010486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 124.